Li-li Ji

The MOE Key Laboratory For Standardization Of Chinese Medicines, Shanghai Key Laboratory Of Compound Chinese Medicines And The SATCM Key Laboratory For New Resources And Quality Evaluation Of Chinese Medicines, 
Shanghai, CN 
The MOE Key Laboratory For Standardization Of Chinese Medicines, Shanghai Key Laboratory Of Compound Chinese Medicines And The SATCM Key Laboratory For New Resources And Quality Evaluation Of Chinese Medicines, 
Shanghai, CN 

Overview

Li-li Ji practices practicing medicine in Shanghai, China.

Her clinical expertise encompasses POEMS Syndrome, Diabetic Retinopathy, and Necrosis.

She is actively involved in clinical research, co-authoring 30 peer reviewed articles.

Gender

Female

Locations

The MOE Key Laboratory For Standardization Of Chinese Medicines, Shanghai Key Laboratory Of Compound Chinese Medicines And The SATCM Key Laboratory For New Resources And Quality Evaluation Of Chinese Medicines, Shanghai, 201203, China
Other Locations
Zhongshan, 200032, China
Meat Processing Key Laboratory Of Sichuan Province, P.R. China, Chengdu, China
Nantong, China
The Ministry Of Education Key Laboratory For Standardization Of Chinese Medicines And Shanghai Key Laboratory Of TCM Complex Prescription, 1200 Cailun Road, Zhangjiang Hi Tech Park, Zhangjiang, 201203, China
Dalian, 116033, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

30 Total Publications

Isotoosendanin inhibits triple-negative breast cancer metastasis by reducing mitochondrial fission and lamellipodia formation regulated by the Smad2/3-GOT2-MYH9 signaling axis.
Isotoosendanin inhibits triple-negative breast cancer metastasis by reducing mitochondrial fission and lamellipodia formation regulated by the Smad2/3-GOT2-MYH9 signaling axis.
Journal: Acta pharmacologica Sinica
Published: January 01, 2024

Frequently Asked Questions about Li-li Ji

Is Li-li Ji a top-rated expert for POEMS Syndrome?

MediFind is an objective health platform that identifies experts based on real-world data. Li-li Ji is classified as an Experienced expert for POEMS Syndrome, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Li-li Ji participate in research or clinical trials?

Yes. Li-li Ji has published 30 articles and abstracts on conditions like POEMS Syndrome. You can view a list of Li-li Ji's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Ji's expertise for a condition
ConditionClose
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile